Printer Friendly

BIO-IMAGING TECHNOLOGIES, INC. SIGNS LETTER OF INTENT TO ACQUIRE MEDICAL COMMUNICATIONS COMPANY

 WEST TRENTON, N.J., Jan. 7 /PRNewswire/ -- Bio-Imaging Technologies, Inc. (NASDAQ: BITI), announced today that it has reached a tentative agreement and signed a letter of intent to acquire TM Marketing, Inc., through the purchase of all of TM's outstanding common stock.
 Bio-Imaging Technologies applies proprietary medical image- processing technology to accelerate the drug and device development and regulatory approval process. TM Marketing, established in 1979, is a privately held medical marketing and communications company based in Hackensack, N.J.
 "This acquisition will help accelerate the commercial application of our medical image-processing technology" said James J. Conklin, M.D., chairman, president and CEO of Bio-Imaging Technologies. "TM Marketing's experienced management, medical communications capabilities and impressive roster of pharmaceutical clients clearly augment our growth strategy," said Conklin.
 Bio-Imaging Technologies provides specialized research services to pharmaceutical, biotechnology and medical device companies. The company utilizes advanced medical imaging techniques such as magnetic resonance imaging, nuclear medicine, computed tomography, and fiberoscopy to facilitate the clinical evaluation and regulatory review of new drugs, diagnostic agents and medical devices.
 Bio-Imaging Technologies applies its technology to visualize and quantitatively analyze product effects in humans or in animals. The company further applies its expertise in image-based data management to prepare fully interactive, computerized regulatory submissions. Bio- Imaging Technologies' clients include Adria Laboratories, Centocor, Inc., Cytogen Corp. and Warner-Lambert Company.
 Bio-Imaging Technologies also applies its medical imaging expertise to support new indications or marketing claims for existing products.
 TM Marketing is a multi-media medical communications firm that has served the healthcare industry for more than 12 years. Included in its credits is the creation and implementation of a national educational medical competition, What's Your Diagnosis?(TM).
 TM also is a leader in computer-assisted graphic design, single- sponsor medical publications and healthcare-related marketing services. TM clients include Bristol-Myers Squibb, Inc., Burroughs-Wellcome Laboratories, Glaxo, Inc., Miles Inc., and Wyeth-Ayerst Laboratories.
 "Bio-Imaging Technologies and TM Marketing are complementary organizations," remarked Mr. Thomas L. Maloof, TM's founder and president. "We will join forces to make leading-edge imaging technology and innovative medical communications available to the healthcare industry. The combined corporation will be unique in its ability to solve some of the more complicated industry problems."
 Completion of the acquisition of TM Marketing by Bio-Imaging Technologies is conditioned upon a period of due diligence, financial review and certain other conditions. The companies anticipate a closing early in 1993.
 /delval/
 -0- 1/7/93
 /CONTACT: John T. Keane, controller and CFO, or William L. Robbins, director, business development, both of Bio-Imaging Technologies, 609-883-2000/
 (BITI)


CO: Bio-Imaging Technologies, Inc.; TM Marketing, Inc. ST: New Jersey IN: CPR SU: TNM

LD-CC -- PH001 -- 2444 01/07/93 07:31 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 7, 1993
Words:442
Previous Article:STORES MAGAZINE PREDICTS BETTER BUSINESS CLIMATE FOR RETAILERS DURING JANUARY
Next Article:CHARMING SHOPPES REPORTS DECEMBER SALES
Topics:


Related Articles
BIO-IMAGING TECHNOLOGIES, INC., APPOINTS WILLIAM J. FITZPATRICK PRESIDENT AND CHIEF OPERATING OFFICER
BIO-IMAGING TECHNOLOGIES, INC. WINS CONTRACTS WORTH $770,000
BIO-IMAGING TECHNOLOGIES, INC. WINS CONTRACTS WORTH $770,000
BIO-IMAGING TECHNOLOGIES, INC. WINS NEW BUSINESS
IMAGING MANAGEMENT ASSOCIATES, INC. SIGNS LETTER OF INTENT TO ACQUIRE DEL CRANE MEDICAL
Bio-Imaging Technologies Announces European Expansion Plans
Bio-Imaging Technologies, Inc. Announces Contract With Schering-Plough Research Institute
CapMed(R) and Interlink Share the Keys to Personal Health.
Neutron Signs Letter of Intent to Acquire up to 67% Interest in Development Stage Bio-Pharmaceutical Company; Products Include Treatment for Female...

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters